Barry A. Gusterson
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
Journal: EBioMedicine
Published: August 22, 2022
De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer.
Journal: Cell death and differentiation
Published: January 26, 2021
Unmasking the immune microecology of ductal carcinoma in situ with deep learning.
Journal: NPJ breast cancer
Published: February 11, 2020
In Regard to Spratt.
Journal: International journal of radiation oncology, biology, physics
Published: July 17, 2018
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: December 18, 2017
Basal-like Breast Cancers: From Pathology to Biology and Back Again.
Journal: Stem cell reports
Published: November 01, 2017
The receptor protein tyrosine phosphatase PTPRB negatively regulates FGF2-dependent branching morphogenesis.
Journal: Development (Cambridge, England)
Published: January 16, 2017
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 09, 2015
RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.
Journal: Disease models & mechanisms
Published: March 15, 2014
Fibulin-2 is involved in early extracellular matrix development of the outgrowing mouse mammary epithelium.
Journal: Cellular and molecular life sciences : CMLS
Published: October 04, 2013
Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.
Journal: The Journal of pathology
Published: October 01, 2012
Last Updated: 09/26/2026